Table 2.
Features of 291 Unique EP Trials Open Across 27 NCCCP Sites Over the Course of July 2010-June 2011
| Trial Features | No. of Trials | % |
|---|---|---|
| Phase | ||
| I | 19 | 7% |
| I/II | 33 | 11% |
| II | 239 | 82% |
| Total unique EP trials | 291* | 100% |
| Sources | ||
| Cooperative Groups | 141 | 48% |
| Industry | 98 | 34% |
| Local | 14 | 5% |
| NCI-designated cancer centers | 31 | 11% |
| Other | 7 | 2% |
| Disease site | ||
| Hematologic | 64 | 22% |
| Lung | 50 | 17% |
| Gastrointestinal | 43 | 15% |
| Breast | 31 | 11% |
| Gynecologic | 30 | 10% |
| Genitourinary | 23 | 8% |
| Brain | 13 | 4% |
| Head and neck | 10 | 3% |
| Melanoma | 8 | 3% |
| Other | 19 | 7% |
| Lead organization (top 10, including ties) | ||
| Southwest Oncology Group | 28 | 10% |
| Eastern Cooperative Oncology Group | 24 | 8% |
| North Central Cancer Treatment Group | 21 | 7% |
| Sarah Cannon Research Institute | 20 | 7% |
| Gynecologic Oncology Group | 20 | 7% |
| Radiation Therapy Oncology Group | 19 | 7% |
| Cancer and Leukemia Group B | 18 | 6% |
| Eli Lilly | 8 | 3% |
| University of Wisconsin | 7 | 2% |
| Children's Oncology Group | 6 | 2% |
| Providence Health & Services | 6 | 2% |
| American College of Surgeons Oncology Group | 5 | 2% |
| University of Nebraska | 5 | 2% |
Abbreviations: CCOP, Community Clinical Oncology Program; EP, early-phase; NCCCP, National Cancer Institute Community Cancer Centers Program; NCI, National Cancer Institute.
*
Number of open EP trials at a site may also reflect EP trials open at a lead site (eg, a lead CCOP site) with which that NCCCP site is affiliated.